These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20386960)

  • 1. Modelling BSE trend over time in Europe, a risk assessment perspective.
    Ducrot C; Sala C; Ru G; de Koeijer A; Sheridan H; Saegerman C; Selhorst T; Arnold M; Polak MP; Calavas D
    Eur J Epidemiol; 2010 Jun; 25(6):411-9. PubMed ID: 20386960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine spongiform encephalopathy (BSE): the end of the beginning or the beginning of the end?
    Bradley R; Liberski PP
    Folia Neuropathol; 2004; 42 Suppl A():55-68. PubMed ID: 15449460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the trend of bovine spongiform encephalopathy prevalence in France: Use of restricted cubic spline regression in age-period-cohort models to estimate the efficiency of control measures.
    Sala C; Morignat E; Ducrot C; Calavas D
    Prev Vet Med; 2009 Jul; 90(1-2):90-101. PubMed ID: 19414204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic.
    Nathanson N; Wilesmith J; Griot C
    Am J Epidemiol; 1997 Jun; 145(11):959-69. PubMed ID: 9169904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk management of transmissible spongiform encephalopathies in Europe.
    Heim D; Kihm U
    Rev Sci Tech; 2003 Apr; 22(1):179-99. PubMed ID: 12793779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific Affairs. American Medical Association.
    Tan L; Williams MA; Khan MK; Champion HC; Nielsen NH
    JAMA; 1999 Jun 23-30; 281(24):2330-9. PubMed ID: 10386559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical BSE risk assessment and its impact on disease detection and dissemination.
    Salman M; Silano V; Heim D; Kreysa J
    Prev Vet Med; 2012 Aug; 105(4):255-64. PubMed ID: 22305879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the time taken for a surveillance system to detect a re-emergence of bovine spongiform encephalopathy in cattle.
    Simons RRL; Arnold ME; Adkin A
    Prev Vet Med; 2017 Mar; 138():48-54. PubMed ID: 28237235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Current questions].
    Brugère-Picoux J
    Bull Acad Natl Med; 1996 Feb; 180(2):291-9; discussion 300-3. PubMed ID: 8705376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine spongiform encephalopathy in the United Kingdom: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):691-4. PubMed ID: 8313487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine spongiform encephalopathy (BSE) and its epidemiology.
    Smith PG; Bradley R
    Br Med Bull; 2003; 66():185-98. PubMed ID: 14522859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the historic recycling risk for BSE in three European countries by calculating the basic reproduction ratio R0.
    Schwermer H; de Koeijer A; Brülisauer F; Heim D
    Risk Anal; 2007 Oct; 27(5):1169-78. PubMed ID: 18076489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on the epidemiology and dynamics of BSE epidemics.
    Ducrot C; Arnold M; de Koeijer A; Heim D; Calavas D
    Vet Res; 2008; 39(4):15. PubMed ID: 18187031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects.
    Smith PG
    Bull World Health Organ; 2003; 81(2):123-30. PubMed ID: 12751420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSE and variant CJD: emerging science, public pressure and the vagaries of policy-making.
    Hueston WD
    Prev Vet Med; 2013 May; 109(3-4):179-84. PubMed ID: 23287715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic.
    Cohen CH; Valleron AJ
    Int J Epidemiol; 1999 Jun; 28(3):526-31. PubMed ID: 10405860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine spongiform encephalopathy: the causal role of ruminant-derived protein in cattle diets.
    Taylor DM; Woodgate SL
    Rev Sci Tech; 1997 Apr; 16(1):187-98. PubMed ID: 9329116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 1.
    Bradley R; Collee JG; Liberski PP
    Folia Neuropathol; 2006; 44(2):93-101. PubMed ID: 16823691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protection from BSE : Efforts, measures, success, and costs].
    Deischl K; Habereder P; Hautmann W; Hellwig M; Ludwig M; Mitschek C; Nottenkämper-Gerth D; Schick M; Sing A; Wildner M; Zapf A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):589-96. PubMed ID: 20449555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bovine spongiform encephalopathy in ruminants and the new variant of Creutzfeldt-Jakob disease in humans].
    Groschup MH
    Dtsch Tierarztl Wochenschr; 1999 Aug; 106(8):329-31. PubMed ID: 10488637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.